School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.
PLoS One. 2013;8(3):e59077. doi: 10.1371/journal.pone.0059077. Epub 2013 Mar 12.
There is some evidence that annual vaccination of trivalent inactivated influenza vaccine (TIV) may lead to reduced vaccine immunogenicity but evidence is lacking on whether vaccine efficacy is affected by prior vaccination history. The efficacy of one dose of TIV in children 6-8 y of age against influenza B is uncertain. We examined whether immunogenicity and efficacy of influenza vaccination in school-age children varied by age and past vaccination history.
We conducted a randomized controlled trial of 2009-10 TIV. Influenza vaccination history in the two preceding years was recorded. Immunogenicity was assessed by comparison of HI titers before and one month after receipt of TIV/placebo. Subjects were followed up for 11 months with symptom diaries, and respiratory specimens were collected during acute respiratory illnesses to permit confirmation of influenza virus infections. We found that previous vaccination was associated with reduced antibody responses to TIV against seasonal A(H1N1) and A(H3N2) particularly in children 9-17 y of age, but increased antibody responses to the same lineage of influenza B virus in children 6-8 y of age. Serological responses to the influenza A vaccine viruses were high regardless of vaccination history. One dose of TIV appeared to be efficacious against confirmed influenza B in children 6-8 y of age regardless of vaccination history.
Prior vaccination was associated with lower antibody titer rises following vaccination against seasonal influenza A vaccine viruses, but higher responses to influenza B among individuals primed with viruses from the same lineage in preceding years. In a year in which influenza B virus predominated, no impact of prior vaccination history was observed on vaccine efficacy against influenza B. The strains that circulated in the year of study did not allow us to study the effect of prior vaccination on vaccine efficacy against influenza A.
有证据表明,每年接种三价灭活流感疫苗(TIV)可能会降低疫苗的免疫原性,但缺乏关于既往接种史是否会影响疫苗效力的证据。TIV 对 6-8 岁儿童乙型流感的一剂效力尚不确定。我们研究了在校儿童流感疫苗接种的免疫原性和效力是否因年龄和既往接种史而有所不同。
我们进行了一项 2009-10 年 TIV 的随机对照试验。记录了前两年的流感疫苗接种史。通过比较接种 TIV/安慰剂前后一个月的 HI 滴度来评估免疫原性。对研究对象进行了 11 个月的随访,记录症状日记,并在急性呼吸道疾病期间采集呼吸道标本,以确认流感病毒感染。我们发现,既往接种与 TIV 对季节性 A(H1N1)和 A(H3N2)的抗体反应降低有关,尤其是在 9-17 岁的儿童中,但在 6-8 岁的儿童中增加了对同一谱系乙型流感病毒的抗体反应。无论接种史如何,对流感 A 疫苗病毒的血清学反应均很高。一剂 TIV 似乎对 6-8 岁儿童确诊的乙型流感有效,无论接种史如何。
既往接种与季节性流感 A 疫苗病毒接种后的抗体滴度升高降低有关,但在先前年份接受同一谱系病毒接种的个体中,对乙型流感的反应更高。在乙型流感病毒占主导的一年中,既往接种史对乙型流感疫苗效力没有影响。研究年度流行的病毒株不允许我们研究既往接种对流感 A 疫苗效力的影响。